Glucose Health
OTC: GLUCBentonville, US · Delaware corporation
Find your way into Glucose Health
Sign up to see every warm intro you have to Glucose Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Glucose Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
FF
Fleming FlemingExecutive
MS
Mark SchaftleinCEO and Director of Issuer
MH
Marc HatchExecutive
MF
Murray FlemingExecutive
JD
John DuffyExecutive
Board
EB
Edmund BurkeBoard director
CJ
Chris JemapeteBoard director
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 12 of 16 rounds · 1900–2026
▶$172.5KraisedOct 2026 · 1 investors · Other Health CareRule 506(b)
▶$172.5KraisedOct 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John DuffyExecutive Officer, Director
- Mark SchaftleinDirector
- Edmund BurkeDirector
- Christopher JemapeteDirector
- Marc HatchExecutive Officer
- Offering amount
- $172.5K
- Amount sold
- $172.5K
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12KraisedOct 2026 · 1 investors · Other Health CareRule 506(b)
▶$12KraisedOct 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John DuffyExecutive Officer, Director
- Mark SchaftleinDirector
- Edmund BurkeDirector
- Christopher JemapeteDirector
- Marc HatchExecutive Officer
- Offering amount
- $12K
- Amount sold
- $12K
- Proceeds to insiders
- $12K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30KraisedOct 2026 · 1 investors · Other Health CareRule 506(b)
▶$30KraisedOct 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John DuffyExecutive Officer, Director
- Mark SchaftleinDirector
- Edmund BurkeDirector
- Christopher JemapeteDirector
- Marc HatchExecutive Officer
- Offering amount
- $30K
- Amount sold
- $30K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10KraisedSep 2026 · 1 investors · ManufacturingRule 506(b)
▶$10KraisedSep 2026 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Mark SchaftleinDirector
- John DuffyExecutive Officer, Director
- marc HatchExecutive Officer
- Edmund BurkeDirector
- Christopher JemapeteDirector
- Offering amount
- $30K
- Amount sold
- $10K
- Minimum investment
- $10K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60KraisedJul 2026 · 1 investors · ManufacturingRule 506(b)
▶$60KraisedJul 2026 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Mark SchaftleinDirector
- Marc HatchExecutive Officer
- Chris JemapeteDirector
- Edmund BurkeDirector
- Offering amount
- $120K
- Amount sold
- $60K
- Minimum investment
- $60K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedFeb 2026 · 1 investors · ManufacturingRule 506(b)
▶$100KraisedFeb 2026 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Marc HatchExecutive Officer
- Mark SchaftleinExecutive Officer, Director
- Chris JemapeteDirector
- Edmunc burkeDirector
- Offering amount
- $100K
- Amount sold
- $100K
- Minimum investment
- $100K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20KraisedDec 2025 · 2 investors · ManufacturingRule 506(b)
▶$20KraisedDec 2025 · 2 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Edmund BurkeDirector
- Fleming FlemingDirector
- Chris JemapeteDirector
- Mark SchaftleinExecutive Officer, Director
- Marc HatchExecutive Officer
- Offering amount
- $20K
- Amount sold
- $20K
- Minimum investment
- $10K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$290KraisedJan 2024 · 5 investors · ManufacturingRule 506(b)
▶$290KraisedJan 2024 · 5 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Murray FlemingExecutive Officer, Director
- Offering amount
- $290K
- Amount sold
- $290K
- Minimum investment
- $15K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Glucose Health raised?
- Glucose Health has disclosed $2.5M raised across 12 of its 16 known rounds.
- Where is Glucose Health headquartered?
- Glucose Health is headquartered in Bentonville, US.